Skip to content
Subscriber Only
Opinion
Faye Flam

IBM’s Watson Hasn’t Beaten Cancer, But A.I. Still Has Promise

The company made bold claims that haven’t yet panned out. But someday artificial intelligence could crack the code of individualized diagnosis and treatment.

Watson, right, was better at “Jeopardy” than at oncology.

Watson, right, was better at “Jeopardy” than at oncology.

Photographer: Ben Hider/Getty Images

It’s a lot harder for a machine to match the best oncologists in cancer treatment than it was to beat human competitors on “Jeopardy.” It’s still a worthy goal. The problem is that so far the artificial-intelligence platform called Watson hasn’t matched the hype generated by IBM’s over-the-top advertising campaign.

Earlier this month, the medical website STAT reported that internal documents from International Business Machines Corp. revealed the computing system had recommended “unsafe and incorrect” cancer treatments. The system is being used in conjunction with human medical judgment, and there are no reports of patients being harmed. But in the documents obtained by STAT, doctors who had tried to use Watson to help them design treatment complained that the system wasn’t ready to practice medicine.